Status:
COMPLETED
Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain
Lead Sponsor:
Mackay Memorial Hospital
Conditions:
Uterine Pain
Eligibility:
FEMALE
20-60 years
Phase:
NA
Brief Summary
To evaluate that perioperative regular usage of propacetamol to reduce post cesarean section uterine contraction pain and opioid consumption
Detailed Description
The most common method of pain control after cesarean section is intravenous patient-control analgesia (IVPCA) with morphine. Multimodal analgesia could improve the quality of perioperative pain contr...
Eligibility Criteria
Inclusion
- Pregnancy more than 36 weeks which is expected to receive Caesarean section
- Post Caesarean section woman, age greater than or equal to 20 years old
- ASA physical status class 1 or 2
Exclusion
- ASA physical status class 3 or above
- Less than 20 years old
- Past caesarean section for longitudinal wounds
- Undergone major abdominal surgery
- Chronic pain
- Allergic to morphine or Propacetamol
- Liver dysfunction
- Treatment with anticoagulant
- Emergency operation
Key Trial Info
Start Date :
August 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03878082
Start Date
August 12 2019
End Date
December 31 2022
Last Update
March 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MacKay Memorial Hospital
Taipei, Taiwan, 104